Moss 27.08.20

Vingulmork Predictor AS, a company controlled by Erling Sundrehagen, Chief
Scientific Officer in Gentian Diagnostics AS (“Gentian”), has today* sold 40,000
shares at NOK 74 per share raising gross proceeds of NOK 2.96 million. The
proceeds will be used to settle tax obligations from a real estate transaction
in Sweden. After the Transaction, Erling Sundrehagen and associated companies
own 184,083 shares and 50,000 options in Gentian. Erling Sundrehagen and
associated companies have entered into a lock-up agreement for 6 months for the
remaining shares they hold in Gentian.

The transaction was done as a block trade towards a large Norwegian
institutional investor

This information is subject to the disclosure requirements set out in section
5-12 of the Norwegian Securities Trading Act.

* The date for the transaction was not included in the original notification. 

For further information, please contact:

Njaal Kind
CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no
Cell Phone: +47 919 06 525